BarryAdamPaulMD

PubMed

• Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study).
  Myra Robinson, Kristen Cassetta, Shanice Borden, Manisha Bhutani, Hamid Ehsan, Peter M Voorhees, Shebli Atrash, Cindy Varga, Mauricio Pineda-Roman, Reed Friend, Barry ...> ;Life. 2024 Mar 14
• Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy.
  Charlotte F M Hughes, Gunjan L Shah, Barry A Paul> ;Frontiers in Oncology. 2024 Jan 1
• The Role of Autologous Stem Cell Transplant in Ultra-High-Risk Myeloma: Do the Ends Still Justify the Means?
  Barry Paul> ;Transplantation and Cellular Therapy. 2023 Dec 1
• Bone marrow Ki-67 index is of prognostic value in newly diagnosed multiple myeloma.
  Shebli Atrash, Myra Robinson, Alankrita Taneja, Barry Paul, Kristen Cassetta, Ami Ndiaye, Cindy Varga, Jared Block, Edward H Lipford, Elton T Smith, Chad M McCall, Vir...> ;European Journal of Haematology. 2023 Sep 1
• A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse.
  Manisha Bhutani, David M Foureau, Myra Robinson, Fei Guo, Kateryna Fesenkova, Shebli Atrash, Barry Paul, Cindy Varga, Reed Friend, Mauricio Pineda-Roman, Katherine Rig...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Jul 1
• 6 citations
  A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma.
  Barry Paul, Michaela Liedtke, Jack Khouri, Robert Rifkin, Mitul D Gandhi, Andrew Kin, Moshe Y Levy, Rebecca Silbermann, Francesca Cottini, Douglas W Sborov, Irwindeep ...> ;Future Oncology. 2023 Jan 1
• 2 citations
  Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study).
  Hamid Ehsan, Alec Britt, Peter M Voorhees, Barry Paul, Manisha Bhutani, Cindy Varga, Zane Chiad, Brittany K Ragon, Al-Ola A Abdallah, Nausheen Ahmed, Shebli Atrash> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Apr 1
• 6 citations
  Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma.
  David M Foureau, Barry A Paul, Fei Guo, Edward H Lipford, Kateryna Fesenkova, Elise Tjaden, Kendra Drummond, Manisha Bhutani, Shebli Atrash, Ami Ndiaye, Cindy Varga, P...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Jan 1
• 2 citations
  Mechanistic Studies and a Retrospective Cohort Study: The Interaction between PPAR Agonists and Immunomodulatory Agents in Multiple Myeloma.
  Jian Wu, Emily Chu, Barry Paul, Yubin Kang> ;Cancers. 2022 Oct 27
• 5 citations
  PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivo.
  Yonggang Sha, Jian Wu, Barry Paul, Yue Zhao, Parker Mathews, Zhiguo Li, John Norris, Endi Wang, Donald P McDonnell, Yubin Kang> ;Cancer Letters. 2022 Oct 1
• 10 citations
  BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy.
  Barry Paul, Cesar Rodriguez, Saad Z Usmani> ;Drugs. 2022 Apr 1
• 7 citations
  Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma.
  David M. Foureau, Manisha Bhutani, Fei Guo, Katherine Rigby, Marina Leonidas, Elise Tjaden, Andee N. Fox, Shebli Atrash, Barry Paul, Peter M. Voorhees, Saad Z. Usmani> ;Cancer Medicine. 2021 Sep 8
• 9 citations
  Transition from Intravenous to Subcutaneous Daratumumab Formulation in Clinical Practice.
  Issam Hamadeh, Donald C Moore, Allison Martin, Allison Karabinos, Hailey Hill, Ami Ndiaye, Jordan Robinson, Barry Paul, Shebli Atrash, Manisha Bhutani, Peter M. Voorhe...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Mar 4
• 2 citations
  Thromboembolism Incidence and Risk Factors in Multiple Myeloma After First Exposure to Immunomodulatory Drug–Based Regimens
  Jai N. Patel, Myra M. Robinson, Megan Jagosky, Daniel Slaughter, Justin Arnall, Elizabeth Jandrisevits, Ashley Matusz-Fisher, Shebli Atrash, Barry Paul, Manisha Bhutan...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Mar 1
• 20 citations
  Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;American Journal of Hematology. 2021 Jan 1
• 12 citations
  Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab.
  Donald C Moore, Justin Arnall, Daniel L. Thompson, Allison L. Martin, Jordan Robinson, Ami Ndiaye, Barry Paul, Shebli Atrash, Manisha Bhutani, Peter M. Voorhees, Saad ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Oct 1
• 2 citations
  An evaluation of subcutaneous daratumumab for the treatment of multiple myeloma.
  Barry Paul, Shebli Atrash, Manisha Bhutani, Peter M. Voorhees, Issam Hamadeh, Saad Z. Usmani> ;Expert Review of Hematology. 2020 Sep 20
• 5 citations
  Daratumumab subcutaneous formulation for the treatment of multiple myeloma
  Barry Paul, Issam Hamadeh, Shebli Atrash, Manisha Bhutani, Peter M. Voorhees, Saad Z. Usmani> ;Expert Opinion on Biological Therapy. 2020 Aug 16
• 5 citations
  The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/...
  Barry Paul, Yue Zhao, Daniel Feinberg, Parker Mathews, Ian Barak, Megan Dupuis, Zhiguo Li, Lindsay A.M. Rein, Endi Wang, Yubin Kang, Gavin Loitsch> ;Cancer Medicine. 2020 Jul 6
• 1 citations
  Management of newly diagnosed transplant ineligible multiple myeloma.
  Shebli Atrash, Manisha Bhutani, Barry Paul, Peter M. Voorhees, Saad Z. Usmani> ;Leukemia & Lymphoma. 2020 Jul 4
• 2 citations
  Gamma Gap: A Point-of-Care Test That Correlates With Disease Burden and Treatment Response in Multiple Myeloma.
  Megan Dupuis, Barry Paul, Gavin Loitsch, Parker Mathews, Daniel Feinberg, Ian Barak, Zhiguo Li, Sascha A. Tuchman, Yubin Kang> ;JCO Oncology Practice. 2020 Apr 2
• 13 citations
  Safety and Cost Benefits of the Rapid Daratumumab Infusion Protocol.
  Issam Hamadeh, Emily S. Reese, Justin Arnall, Ekaterina Kachur, Allison L. Martin, Meghan Schneider, Reed Friend, Barry Paul, Shebli Atrash, Manisha Bhutani, Peter M. ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Mar 7
• 24 citations
  PINK1-Dependent Mitophagy Regulates the Migration and Homing of Multiple Myeloma Cells via the MOB1B-Mediated Hippo-YAP/TAZ Pathway.
  Shengjun Fan, Trevor T. Price, Wei Huang, Michelle Plue, Jonathan Warren, Pasupathi Sundaramoorthy, Barry Paul, Daniel Feinberg, Nancie J. MacIver, Nelson J. Chao, Dor...> ;Advanced Science. 2020 Jan 23
• 16 citations
  The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma
  Daniel Feinberg, Barry Paul, Yubin Kang> ;Cellular Immunology. 2019 Nov 1
• 358 citations
  Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Leukemia. 2019 Sep 1
• Join now to see all

Lectures

• The presence of bone marrow fibrosis is associated with poorer prognosis in newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inh... 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019